A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT04540796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

DRUG: JNJ-75348780

Sponsor

Janssen Research & Development, LLC